Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001140361-23-040560

EVP, Chief Medical Officer sold 6,975 shares at an average $1.65 ($11,526)

From the SEC's structured data for this filing

Trades in this filing

Joshi Manher · EVP, Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-08-16 Sale : show line 1 in the form −3,202 $1.65 $5,290 187,344 D
2023-08-16 Sale : show line 2 in the form −3,773 $1.65 $6,237 183,571 D
Open-market sales · 6,975 sh · avg $1.65 · $11,526
Loading xslF345X05/form4.xml…